GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neurogene Inc (NAS:NGNE) » Definitions » DeferredTaxAndRevenue

Neurogene (Neurogene) DeferredTaxAndRevenue : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Neurogene DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Neurogene's current deferred tax and revenue for the quarter that ended in Mar. 2024 was $0.00 Mil.

Neurogene DeferredTaxAndRevenue Historical Data

The historical data trend for Neurogene's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurogene DeferredTaxAndRevenue Chart

Neurogene Annual Data
Trend Dec21 Dec22 Dec23
DeferredTaxAndRevenue
- - -

Neurogene Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
DeferredTaxAndRevenue Get a 7-Day Free Trial - - - - -

Neurogene DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of Neurogene's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Neurogene (Neurogene) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
535 W 24th Street, 5th Floor, New York, NY, USA, 10011
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Neurogene (Neurogene) Headlines